top of page
Search

As biotech gravitates to machine learning and AI, insitro's founder shares her experience of working this way since 2018

  • blonca9
  • Feb 21, 2024
  • 1 min read

Daphne Koller describes the platform insitro has been building since it was founded in 2018, explains how she thinks the company is differentiated, and provides an update on the company's progress.



Join the BiotechTV mailing list

Thanks for subscribing!

Follow BiotechTV

  • Twitter

@BiotechTVHQ

  • LinkedIn

BiotechTV

  • Facebook

BiotechTVHQ

  • TikTok

@BiotechTV

  • Instagram

@BiotechTVHQ

Also look for unique social pages for BiotechTV U.

Sponsor Spotlight

Allucent logo_tagline.png

Allucent Clinical Research Organization™ is on a mission to help bring new therapies to light by solving the distinct challenges of small and mid-sized biotech companies. We’re a global provider of comprehensive drug development solutions, including consulting, clinical operations, biometrics, and clinical pharmacology across a variety of therapeutic areas.

Learn more about Allucent

bottom of page